Publication details
Průběžné zprávy Mezinárodní prospektivní studie u dětí s meduloblastomem (MB) starších 3 let a WNT biologickým profilem (PNET 5 MB - LR a PNET 5 MB - WNT-HR), standardně rizikovým biologickým profilem (PNET 5 MB - SR), nebo mutací TP53, a registr výskytu MB v kontextu genetické predispozice.
| Title in English | Interim reports INTERNATIONAL PROSPECTIVE TRIAL MEDULLOBLASTOMA (MB) IN CHILDREN OLDER THAN 3 TO 5 YEARS WITH WNT BIOLOGICAL PROFILE (PNET 5 MB - LR and PNET 5 MB - WNT-HR), AVERAGE-RISK BIOLOGICAL PROFILE (PNET 5 MB -SR), OR TP53 MUTATION AND REGISTRY |
|---|---|
| Authors | |
| Year of publication | 2021 |
| MU Faculty or unit | |
| Web | PNET |
| Description | PNET EudraCT number: 2011-004868-30 Semi-Annual reports on the progress of clinical trials describe the course of clinical trial in the observed period and the current status of trial. These reports include information on document updates, screening, number of newly enrolled patients, general overview of patients enrolled so far, number of prematurely discontinued patients in the Czech Republic, incidence of serious adverse events, identified protocol violations, information on newly identified findings on investigational medicinal product in relation to its safety and efficacy, newly adopted measures (eg interventions of ethics committees, foreign control authorities, possible restrictive interventions of the contracting authority) and information on performed internal audits or audits by the contracting authority if applicable. |
| Related projects: |